Leaflet REDERGIN 1mg/ml 0.1% oral drops solution


Indicated for: cognitive disorders; cerebral circulatory disorders

Route of administration: oral

Substance: codergocrine (alkaloid derivative)

ATC: C04AE01 (Cardiovascular system | Peripheral vasodilators | Ergot alkaloids)

Codergocrine is an ergot derivative used for the treatment of cerebral and peripheral circulatory disorders. It works by improving blood flow and reducing vascular resistance, helping to alleviate associated symptoms.

The medication is administered orally or by injection, as directed by a doctor. It is important for patients to follow the treatment regimen and inform the doctor about any other medications being used.

Patients should be aware of potential side effects, such as nausea, dizziness, or allergic reactions. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, dizziness, and headaches. In rare cases, severe reactions such as vasospasm or allergic reactions may occur. Patients should be informed of these risks before use.

General data about REDERGIN 1mg/ml 0.1%

  • Substance: codergocrine
  • Date of last drug list: 01-10-2015
  • Commercial code: W01424001
  • Concentration: 0.1%
  • Pharmaceutical form: oral drops solution
  • Quantity: 1
  • Product type: generic
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Pharmaceutical forms available for codergocrine

Concentrations available for codergocrine

  • 0.1%
  • 0.3mg/ml
  • 1mg/ml